Fludarabine/melphalan conditioning for allogeneic stem cell transplantation (SCT) in elderly patients with AML/MDS

被引：0
|
作者：
Kennedy, GA
Butler, J
Durrant, S
Hill, GR
Western, R
Morton, J
机构：
[1] Royal Brisbane & Womens Hosp, Div Oncol, Brisbane, Qld, Australia
[2] Queensland Inst Med Res, Brisbane, Qld 4006, Australia
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5410
引用
收藏
页码：438B / 439B
页数：2
相关论文
共 50 条
  • [21] Reduced intensity conditioning with Fludarabine, BCNU and Melphalan (FBM) for allogeneic hematopoietic cell transplantation in elderly AML patients: remission status at transplant predicts outcome
    Wais, V.
    Kuendgen, L.
    Bohl, S.
    von Harsdorf, S.
    Schlenk, R. F.
    Doehner, K.
    Teleanu, V.
    Bullinger, L.
    Drognitz, K.
    Moulin, J. -C.
    Binnenhei, M.
    Bentz, M.
    Doehner, H.
    Bunjes, D.
    Ringhoffer, M.
    Kuchenbauer, F.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S442 - S443
  • [22] Dose-reduced conditioning followed by allogeneic stem cell transplantation in patients with MDS or secondary AML
    Kröger, N
    Schwerdtfeger, R
    Bornhäuser, M
    Ehninger, G
    Runde, V
    Beyer, J
    Kiehl, M
    Schetelig, J
    Siegert, W
    Schäfer-Eckert, K
    Wandt, H
    Sayer, HG
    Kröger, M
    Zabelina, T
    Zander, AR
    BONE MARROW TRANSPLANTATION, 2002, 29 : S57 - S57
  • [23] Outcomes of Elderly Patients Undergoing Allogeneic Transplantation for Acute Myeloid Leukemia with Fludarabine/Melphalan or Fludarabine/TBI Conditioning Regimen
    Woods, Ashley C.
    Joseph, Nisha
    Rupji, Manali
    Liu, Yuan
    Langston, Amelia
    Waller, Edmund K.
    BLOOD, 2019, 134
  • [24] Treosulfan/fludarabine as dose-reduced conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with AML and MDS/sAML
    Kröger, N
    Zabelina, T
    Schieder, H
    Kratochwille, K
    Ayuk, F
    Stute, N
    Fehse, N
    Hassenpflug, J
    Panse, J
    Casper, J
    Freund, M
    Zander, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S256 - S256
  • [25] COMPARISON OF FLUDARABINE-MELPHALAN AND FLUDARABINE-TREOSULFAN AS CONDITIONING REGIMENS PRIOR TO ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Liga, Maria
    Tsokanas, Dimitris
    Sagiadinou, Eleftheria
    Lysandrou, Memnon
    Georgopoulou, Angeliki
    Triantafyllou, Evangelia
    Zacharioudaki, Vassiliki
    Christopoulou, Anastasia
    Spyridonidis, Alexandros
    BONE MARROW TRANSPLANTATION, 2024, 59 : 273 - 274
  • [26] A conditioning regimen of busulfan, fludarabine, and melphalan for allogeneic stem cell transplantation in children with juvenile myelomonocytic leukemia
    Yabe, Miharu
    Sako, Masahiro
    Yabe, Hiromasa
    Osugi, Yuko
    Kurosawa, Hidemitsu
    Nara, Taemi
    Tokuyama, Mika
    Adachi, Souichi
    Kobayashi, Chie
    Yanagimachi, Masakatsu
    Ohtsuka, Yoshitoshi
    Nakazawa, Yozo
    Ogawa, Chitose
    Manabe, Atsushi
    Kojima, Seiji
    Nakahata, Tatsutoshi
    PEDIATRIC TRANSPLANTATION, 2008, 12 (08) : 862 - 867
  • [27] Second Allogeneic Stem-Cell Transplantation (SCT) From a Different Donor for the Treatment of Relapsed AML and MDS After a Previous Allogeneic SCT
    Shimoni, Avichai
    Shem-Tov, Noga
    Volchek, Yulia
    Yerushalmi, Ronit
    Nagler, Arnon
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S229 - S229
  • [28] Second allogeneic stem-cell transplantation (SCT) from a different donor for the treatment of relapsed AML and MDS after a previous allogeneic SCT
    Shimoni, A.
    Shem-Tov, N.
    Volchek, Y.
    Yerushalmi, R.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S248 - S249
  • [29] Fludarabine (Flu) and IV busulfan (Bu)±ATG:: Low toxicity conditioning regimen for stem cell transplantation (SCT) in AML and MDS -: Preliminary results.
    deLima, M
    Shahjahan, M
    Madden, T
    Tran, HT
    Gajewski, JL
    Couriel, DR
    Giralt, S
    Donato, ML
    Anderlini, P
    Korbling, M
    Khouri, I
    Russell, JA
    Champlin, RE
    Andersson, BS
    BLOOD, 2001, 98 (11) : 345B - 345B
  • [30] Fludarabine melphalan versus fludarabine treosulfan for reduced intensity conditioning regimen in allogeneic hematopoietic stem cell transplantation: a retrospective analysis
    Chichra, Akanksha
    Nayak, Lingaraj
    Kothari, Rushabh
    Kalantri, Siddhesh
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Mirgh, Sumeet
    Jindal, Nishant
    Bagal, Bhausaheb
    Kannan, Sadhana
    Mathew, Libin
    Khattry, Navin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (01) : 71 - 79
12345